From Nurse to Patient
February 06, 2014 17:44 ET
|
Genentech
MISSION, KS--(Marketwired - Feb 6, 2014) - (Family Features) Despite her career as a scrub nurse for general cancer surgeries, a personal diagnosis of cancer still came as a surprise.
"It...
MMRGlobal Receives Cancer-Fighting Anti-CD20 Monoclonal Antibodies Patent in Korea
January 31, 2014 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program
August 26, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 26, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
Lack of Information Biggest Barrier for Lymphoma Patients
December 21, 2012 15:54 ET
|
Lymphoma Coalition
Mississauga, Ontario, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Lack of basic, but crucial, information acts as a barrier to the
proper diagnosis and treatment of lymphoma patients worldwide. This
contributes...
MMRGlobal to File Anti-CD20 Antibody and B-Cell Vaccine Patents Targeting Cancers
July 27, 2012 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - Jul 27, 2012) - MMRGlobal, Inc. (www.mmrglobal.com) (OTCBB: MMRF) ("MMR") today announced that it is filing two additional divisional patent applications that are...
Semafore Pharmaceuticals Announces Presentation Highlighting Activity of Multi-Kinase, PI3K/mTOR Inhibitor SF1126 at 2011 AACR Annual Meeting
March 09, 2011 07:30 ET
|
Semafore Pharmaceuticals
INDIANAPOLIS, March 9, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals announced today that preclinical data in B-cell malignancies for the company's lead product candidate SF1126 will be presented...
MMRGlobal Settles With Lymphoma Research Foundation
November 30, 2010 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - November 30, 2010) - MMRGlobal, Inc. (OTCBB: MMRF) (MMR) today announced it has signed a settlement agreement with the Lymphoma Research Foundation (LRF), resolving its...
MMR Information Systems, Inc. Receives Grant From U.S. Patent and Trademark Office to Reinstate Patent to Treat Patients With B-Cell Malignancies
June 11, 2010 11:26 ET
|
MMR Information Systems, Inc.
LOS ANGELES, CA--(Marketwire - June 11, 2010) - MMR Information Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com) announced today that a petition has been granted by the U.S. Patent and...
UPDATE: MMR Information Systems, Inc. Creates Biotech Dream Team With the Addition of Biotech Experts Fred Middleton and Dr. Ivor Royston to Its Board of Advisors
May 26, 2010 15:34 ET
|
MMR Information Systems, Inc.
LOS ANGELES, CA--(Marketwire - May 26, 2010) - MMR Information Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com) announced today that Fred Middleton, Managing Director of Sanderling...
MMR Information Systems, Inc. Creates Biotech Dream Team With the Addition of Biotech Experts Fred Middleton and Dr. Ivor Royston to Its Board of Advisors
May 25, 2010 08:35 ET
|
MMR Information Systems, Inc.
LOS ANGELES, CA--(Marketwire - May 25, 2010) - MMR Information Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com) announced today that Fred Middleton, Managing Director of Sanderling...